Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fendrix vs Double Dose Engerix-B in Dialysis Patients
NCT00383383Phase 3Completed
- Sponsor
- GSK
- Start
- Dec 1999
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
Phase 3, randomised, open-label trial of hepatitis b vaccine recombinant in hepatitis B (HBV) (2 arms), sponsored by GSK. Primary endpoint: Anti-HBs seroprotection rates at 12 months. Started Dec 1999; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00383383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00383383.